
Lisinopril
CAS number: 76547-98-3
Molecular formula: C21H31N3O5
molecular weight: 405.49
Chemical structure:
Producers shown on SFDA
(Record date:02/09/2021)
Producer | Documents | GMP Valid till(based on SFDA) |
Zhongfu Pharmaceutical Co., Ltd. | GMP | Valid till October 2021 |
Zhejiang Huahai Pharmaceutical Co., Ltd. | GMP, DMF | Valid till October 2021 |
Producers shown on EP
(Quoted from EP website;record date:02/09/2021)
Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
Lisinopril dihydrate Process II | HETERO DRUGS LIMITED IN 500 018 Hyderabad | R0-CEP 2016-197-Rev 04 | 21/10/2020 | VALID | / | Chemistry |
Lisinopril dihydrate | GEDEON RICHTER PLC HU 1103 Budapest | R1-CEP 1999-051-Rev 03 | 23/03/2011 | WITHDRAWN BY HOLDER | 16/04/2015 | Chemistry |
Lisinopril dihydrate | Ranbaxy Laboratories Limited IN 122 015 Gurgaon | R1-CEP 2000-121-Rev 04 | 16/03/2011 | WITHDRAWN BY HOLDER | 24/03/2015 | Chemistry |
Lisinopril dihydrate | LEK PHARMACEUTICALS D.D. SI 1526 Ljubljana | R0-CEP 2006-065-Rev 00 | 12/08/2008 | WITHDRAWN BY HOLDER | 13/12/2012 | Chemistry |
Lisinopril dihydrate | MYLAN LABORATORIES LIMITED IN 502 325 Hyderabad | R1-CEP 2008-134-Rev 01 | 29/09/2014 | WITHDRAWN BY HOLDER | 18/02/2019 | Chemistry |
Lisinopril dihydrate | ZHEJIANG CHANGMING PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai | R1-CEP 2011-002-Rev 00 | 23/01/2017 | VALID | / | Chemistry |
Lisinopril dihydrate | AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad | R1-CEP 2003-211-Rev 04 | 13/12/2017 | WITHDRAWN BY HOLDER | 25/11/2019 | Chemistry |
Lisinopril dihydrate | EVONIK OPERATIONS GMBH DE 45128 Essen | R1-CEP 2004-011-Rev 07 | 09/12/2020 | VALID | / | Chemistry |
Lisinopril dihydrate | Farmhispania, S.A. ES 08160 Montmeló | R1-CEP 2005-249-Rev 02 | 02/04/2015 | VALID | / | Chemistry |
Lisinopril dihydrate | LUPIN LIMITED IN 400 055 Mumbai | R1-CEP 2001-311-Rev 04 | 27/09/2019 | VALID | / | Chemistry |
Lisinopril dihydrate | ESTEVE QUIMICA S.A. ES 08024 Barcelona | R1-CEP 1999-024-Rev 04 | 30/06/2015 | WITHDRAWN BY HOLDER | 12/09/2018 | Chemistry |
Lisinopril dihydrate | ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. CN 317 024 Linhai | R1-CEP 2003-064-Rev 04 | 04/12/2018 | VALID | / | Chemistry |
Lisinopril dihydrate | UNIMARK REMEDIES LIMITED IN 400 062 Mumbai | R1-CEP 2004-063-Rev 04 | 11/03/2020 | VALID | / | Chemistry |
Lisinopril dihydrate | HETERO DRUGS LIMITED IN 500 018 Hyderabad | R1-CEP 2012-370-Rev 00 | 21/02/2020 | VALID | / | Chemistry |
Lisinopril dihydrate | RICHTER THEMIS MEDICARE (I) PVT. LTD. IN 396 195 Vapi | R0-CEP 2018-223-Rev 00 | 14/05/2020 | VALID | / | Chemistry |
Producer:Zhongfu Pharmaceutical Co., Ltd. (formerly Shandong Weifang Pharmaceutical Factory Co., Ltd.), founded in 1966 and restructured in 2000, now covers an area of about 100 mu.
The company produces five series of products with 74 varieties and 120 specifications throughout the year. The main production capacity is 300 million small volume injections, 200 million sterile powder injections, 1 billion tablets, 500 million capsules and 350 tons of API. At present, all the production workshops have passed the GMP certification of the State Food and drug administration, of which captopril API has passed the FDA certification of the United States and obtained the cos certificate of EU EDQM.
Staff size:200-299 persons
Registered capital:RMB 78.364 million
Producer:Zhejiang Huahai Pharmaceutical Co., Ltd.was founded in 1989 and headquartered in Zhejiang, China. The company has nearly 7000 employees and more than 40 subsidiaries around the world (including China, the United States, Japan, Germany, etc.As a leading enterprise in the internationalization of Chinese medicine, Huahai pharmaceutical is the first pharmaceutical company in China to pass the FDA preparation quality certification and independently own the Anda document number. It is also the first Chinese pharmaceutical company to realize large-scale preparation sales in the United States. It has established China's pharmaceutical quality image in the world's high-end pharmaceutical market.
Staff size:About 7000 persons
Registered capital:RMB 1 billion 492 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978